Pharmaceutical Industry — Landmark Events

Landmark Events

Novartis AG vs Union of India

2013

The Supreme Court's rejection of Novartis's patent application for Glivec (imatinib mesylate) under Section 3(d) of the Patents Act established India's stringent patentability…

Bayer Corporation vs Union of India

2012

India's first compulsory license granted for Bayer's cancer drug Nexavar (sorafenib tosylate) to Natco Pharma established precedent for using compulsory licensing to ensure…